Increased Carrier Concentration in Zno/Cui Heterojunction Diode

Total Page:16

File Type:pdf, Size:1020Kb

Load more

RSC Advances View Article Online PAPER View Journal | View Issue L-Alanine capping of ZnO nanorods: increased carrier concentration in ZnO/CuI heterojunction Cite this: RSC Adv.,2018,8, 5350 diode† E. Indubala,ac M. Dhanasekar,be V. Sudha,c E. J. Padma Malar,d P. Divya,d Jositta Sherine,e Revathy Rajagopal,f S. Venkataprasad Bhatbe and S. Harinipriya *ac ZnO nanorods were capped with a simple amino acid, viz., L-alanine to increase the carrier concentration and improve the performance of ZnO/CuI heterojunction diodes. The effect of L-alanine capping on the morphology, structural, optical, electrochemical and electrical properties of ZnO nanorods had been studied in detail. The stable structure with two equally strong Zn–O coordinate bonds predicted by Received 13th November 2017 density functional theory was in agreement with the experimental results of FTIR spectroscopy. Due to Accepted 16th January 2018 the presence of electron-releasing (+I effect) moieties in L-Alanine, the carrier concentration of capped DOI: 10.1039/c7ra12385j ZnO nanorods was two orders of magnitude higher and the ZnO/CuI heterojunction device showed Creative Commons Attribution 3.0 Unported Licence. rsc.li/rsc-advances more than a two-fold increase in the photovoltaic power conversion efficiency. 1 Introduction semiconductor QDs such as CdS,2 CdSe,3–5 and PbSe4 via ligand induced surface dipoles. Ligands are ions or molecules attached to the central metal Transparent conducting materials such as ZnO and Al-doped – atom via coordinating bonds. By attaching two or three different ZnO have been utilized as unipolar n-type semiconductors6 9 in ligands to the surface of a single nanoparticle, electric elds diode applications.10,11 Capping, surface modication and large enough to signicantly alter the electronic and optoelec- substitution of ZnO for various applications have been studied 1,12–19 This article is licensed under a tronic properties of the nanocrystals could be induced. Ligands extensively in the literature. Thus, a simple route to such as amino acids, polyamines, and thiols can act as good improve the carrier concentration of n-type semiconductors capping agents due to their inductive effect and surface induced such as ZnO and to enhance the efficiency of heterojunction dipoles on the capped materials. Surface capping of nano- and photovoltaic devices has become inevitable. Surface Open Access Article. Published on 31 January 2018. Downloaded 9/26/2021 7:31:19 PM. crystals with mixed ligands plays a vital role to enhance the modication of ZnO nanoparticles (NPs) by n-propylamine and performance of quantum dots (QDs) based optoelectronic thiols inuences the electronic memory effect of ZnO–poly- devices via tuning of the electronic energy levels. The energy styrene diodes.12 Methods of surface modication and the level tuning depends strongly on the surface linking groups and inuence of surface substitution on the electronic properties of the ratio of the different capping molecules attached to the ZnO surfaces at molecular interfaces of hybrid photovoltaic surface of the QDs.1 Ligand exchange and complexation are (hPV) and organic photovoltaic (OPV) devices have been exten- widely used to modify the electronic properties of sively studied in the literature.15 Surface modied ZnO NPs showed signicant enhancement in the spectrum selectivity and absorption efficiency in the UV range.16 The 1,2-ethanedi- thiol (EDT) doped ZnO composite behaved as an electron aElectrochemical Systems Lab, SRM Research Institute, SRM Institute of Science and transporting layer to improve the performance of inverted – Technology, Kattankulathur, Chennai 603203, India. E-mail: harinipriya.s@res. polymer solar cells.17 The strong interaction between ZnO and srmuniv.ac.in – b the SH group of EDTs contributed to the formation of SRM Research Institute, SRM Institute of Science and Technology, Kattankulathur, – Chennai – 603203, India a homogeneous lm of ZnO EDT by passivating the surface ff cDepartment of Chemistry, SRM Institute of Science and Technology, Kattankulathur, defects and increasing the electron mobility of ZnO e ectively. Chennai – 603203, India It was demonstrated in the literature that ZnO–EDT increased dNational Centre for Ultrafast Processes, University of Madras, Taramani Campus, the electron extraction and facilitated more photoinduced Chennai – 600 113, India carrier generation than unpassivated ZnO. The space-charge e Department of Physics and Nanotechnology, SRM Institute of Science and Technology, limited current (SCLC) measurements were performed to Kattankulathur, Chennai – 603203, India determine the change in electron mobility of ZnO with and fDepartment of Chemistry, Stella Maris College, Chennai – 600086, India 20,21 † Electronic supplementary information (ESI) available. See DOI: without doping. The electron mobility of the device with – 10.1039/c7ra12385j ZnO 0.5% EDT was more than double of that with bare ZnO; it 5350 | RSC Adv.,2018,8, 5350–5361 This journal is © The Royal Society of Chemistry 2018 View Article Online Paper RSC Advances was suggested that the higher electron mobility may be due to stirred for up to 24 h. Aer stirring, ZnO–L-alanine composites the good crystallinity and surface defect passivation.17 Accord- were separated by centrifugation at 1000 rpm for 15 min. The ing to another report,22 band gap engineering of PbS QDs via separated precipitate was dried in a hot-air oven for 24 h to encapsulation of PbS using complexing ligands such as EDT obtain ZnO–L-Alanine. increased the efficiency of the ZnO/PbS heterojunction upto 8.55%. 2.3 Synthesis of CuI nanoowers from Syzygium cumini Surface modication of ZnO NPs by amino acids such as extract 22,23 L-Alanine and L-Arginine has been reported in the literature Syzygium cumini or naval fruit seeds were washed several times 23 for band gap engineering and thermo-optic applications. thoroughly under running water and rinsed with distilled water. 3+ + L-Arginine capped Nd and Li co-doped CdS QDs have been The cleaned seeds were then soaked in distilled water for 24 h. 24 utilized in the literature to demonstrate a large blue shi in The soaked seeds were ground into a paste using a mixer. The band gap energy, as compared to that of bulk CdS, due to the resultant paste was diluted with distilled water and stirred ff quantum con nement e ect. Water soluble CuS QDs have been continuously for 3 h to attain homogeneity. The subsequent ffi prepared e ciently using alanine as a bio-compatible organic solution was then centrifuged. The centrifugate was used for capping molecule.25 In the present study, we employed a simple $ synthesis of CuI nano owers. Cu(NO3)2 3H2O and NaI were precipitation method to synthesize ZnO nanorods (NRs) with purchased from Qualigens and SDFCL, respectively, and were L-Alanine as the capping agent to improve the carrier concen- used without further purication. Initially, 30 mL of Syzygium tration and performance of ZnO/CuI and ZnO–L-Alanine/CuI cumini extract was added dropwise into 2 g of Cu(NO3)2$3H2O, heterojunction diodes, respectively. Although several amino which was dissolved in 75 mL of distilled water under magnetic acids can be used for the present study, alanine was chosen as it stirring. Then, 1.2408 g of NaI dissolved in 75 mL of distilled is the simplest chiral amino acid available abundantly in water was added dropwise into the above solution. The obtained nature. Speci cally, the L-enantiomer of alanine was preferred mixture was stirred at room temperature. The resultant dark ff Creative Commons Attribution 3.0 Unported Licence. to accommodate e ective coordination bonding with ZnO NRs. brown precipitate was ltered, washed thoroughly with 50% ff – – In addition, the electron-releasing (+I e ect) of CH3, COOH ethanol and dried at 50 C. and –NH2 groups present in alanine facilitated the electron-rich surface for ZnO by passivating the surface defects and 2.4 Materials characterization increasing the electron mobility of ZnO effectively. Due to the – high aspect ratio, one-dimensional electronic percolation and XRD of ZnO, ZnO L-Alanine and CuI were obtained using ff a l carrier mobility in NRs enabled it to be a feasible candidate for a Bruker D8 Advance di ractometer using CuK radiation and ¼ capping studies in comparison with other geometries.26 Studies 1.5406 A. The morphology of the above-mentioned compounds was analyzed by SEM-EDS analysis (Carl Zeiss- on the effect of L-Alanine capping on the structural, optical, This article is licensed under a electrical and electrochemical properties of ZnO NRs were SEM, EDS-Oxford Instruments). Surface morphology was carried out in detail. Theoretical investigations based on density studied by a metallurgical microscope (LEICA DM Model no. 1). functional theory were performed to understand the structural Optical measurements were carried out using a UV-Vis spec- trophotometer (Specord 200 plus, Analytikjena, Germany) in –L Open Access Article. Published on 31 January 2018. Downloaded 9/26/2021 7:31:19 PM. stability and geometry of ZnO -Alanine that supports the ff – carrier concentration increase due to the +I effect. Further, the di use re ectance spectral (DRS) mode. FTIR of ZnO and ZnO positive contribution of this +I effect on the photocurrent L-Alanine NRs were performed by Bruker FTIR. Photo- generation in the ZnO/CuI heterojunction device was also luminescence spectroscopic analysis of ZnO and L-alanine demonstrated. capped ZnO NRs was carried out using a Fluorolog Horiba spectrophotometer. The surface morphology and structural studies of green-synthesized CuI nanoowers are provided in 2 Experimental section Fig. S1 and S2 and Table S1 of the ESI.† 2.1 Synthesis of ZnO NRs À 2.5 Quantum chemical study Zinc sulfate (1.5 mol L 1) and ammonium bicarbonate À (2.5 mol L 1) were prepared in distilled water and 100 mL of The interaction between L-Alanine and ZnO molecule was studied in the gas-phase starting from the lowest energy alanine ZnSO4 solution was added to 126 mL of NH4HCO3 solution with 27 ff stirring at 45 C.
Recommended publications
  • Physicochemical Properties of Organic Medicinal Agents

    Physicochemical Properties of Organic Medicinal Agents

    Principles of Drug Action 1, Spring 2005, Esters ESTERS AND RELATED CARBOXYLIC ACID DERIVATIVES Jack DeRuiter I. Structure and Preparation Esters are derivatives of carboxylic acids that arise via replacement of the hydroxyl (OH) portion of the acid COOH function with an "ether" moiety (-OR): O O H C C O C O Acid Ester Note that replacement of the acid OH group with an "ether" moiety removes the acidic function from the parent structure (acid) resulting in the formation of non-acidic (neutral, but somewhat polar) compounds (esters). Esters can be sub-classified based on their general structure as aliphatic, aromatic or cyclic (called "lactones") as illustrated by the examples below: O O CH2CH3 CH2CH3 O CH3 O O O Aliphatic Ester Aromatic Ester Cyclic Ester (Lactone) A variety of methods have been developed for the preparation of esters. Most of these methods involve reaction of an alcohol with an "activated carboxylic acid" compound (i.e. acid chloride): O O H C C X OC C O X- Ester "Activated" acid (X=Cl) Alcohol (Electrophile) (Nucleophile) The ester functionality does not introduce a center of asymmetry and thus optical and geometric isomerism does not result from the presence of this functional group. The ester functionality (the carbonyl and ether oxygen) is composed of an sp2 hybridized carbon so it cannot be chiral, and since there is free rotation about the ether bond geometric isomerism also is not possible at the sp2 center. 1 Principles of Drug Action 1, Spring 2005, Esters II. Solubility of Esters Esters contain carbonyl (C=O) and ether (O-C) dipoles arising from covalent bonding between electronegative oxygen atoms and electronically neutral carbon atoms.
  • Biosynthesis of Natural Products Containing Β-Amino Acids

    Biosynthesis of Natural Products Containing Β-Amino Acids

    Natural Product Reports Biosynthesis of natural products containing β -amino acids Journal: Natural Product Reports Manuscript ID: NP-REV-01-2014-000007.R1 Article Type: Review Article Date Submitted by the Author: 21-Apr-2014 Complete List of Authors: Kudo, Fumitaka; Tokyo Institute Of Technology, Department of Chemistry Miyanaga, Akimasa; Tokyo Institute Of Technology, Department of Chemistry Eguchi, T; Tokyo Institute Of Technology, Department of Chemistry and Materials Science Page 1 of 20 Natural Product Reports NPR RSC Publishing REVIEW Biosynthesis of natural products containing βββ- amino acids Cite this: DOI: 10.1039/x0xx00000x Fumitaka Kudo, a Akimasa Miyanaga, a and Tadashi Eguchi *b Received 00th January 2014, We focus here on β-amino acids as components of complex natural products because the presence of β-amino acids Accepted 00th January 2014 produces structural diversity in natural products and provides characteristic architectures beyond that of ordinary DOI: 10.1039/x0xx00000x α-L-amino acids, thus generating significant and unique biological functions in nature. In this review, we first survey the known bioactive β-amino acid-containing natural products including nonribosomal peptides, www.rsc.org/ macrolactam polyketides, and nucleoside-β-amino acid hybrids. Next, the biosynthetic enzymes that form β-amino acids from α-amino acids and de novo synthesis of β-amino acids are summarized. Then, the mechanisms of β- amino acid incorporation into natural products are reviewed. Because it is anticipated that the rational swapping of the β-amino acid moieties with various side chains and stereochemistries by biosynthetic engineering should lead to the creation of novel architectures and bioactive compounds, the accumulation of knowledge regarding β- amino acid-containing natural product biosynthetic machinery could have a significant impact in this field.
  • New Conceptual Understanding of Lewis Acidity, Coordinate Covalent Bonding, and Catalysis Joshua A

    New Conceptual Understanding of Lewis Acidity, Coordinate Covalent Bonding, and Catalysis Joshua A

    Duquesne University Duquesne Scholarship Collection Electronic Theses and Dissertations Summer 2009 New Conceptual Understanding of Lewis Acidity, Coordinate Covalent Bonding, and Catalysis Joshua A. Plumley Follow this and additional works at: https://dsc.duq.edu/etd Recommended Citation Plumley, J. (2009). New Conceptual Understanding of Lewis Acidity, Coordinate Covalent Bonding, and Catalysis (Doctoral dissertation, Duquesne University). Retrieved from https://dsc.duq.edu/etd/1052 This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Duquesne Scholarship Collection. For more information, please contact [email protected]. NEW CONCEPTUAL UNDERSTANDING OF LEWIS ACIDITY, COORDINATE COVALENT BONDING, AND CATALYSIS A Dissertation Submitted to the Bayer School of Natural and Environmental Sciences Duquesne University In partial fulfillment of the requirements for the degree of Doctor of Philosophy By Joshua A. Plumley August 2009 NEW CONCEPTUAL UNDERSTANDING OF LEWIS ACIDITY, COORDINATE COVALENT BONDING, AND CATALYSIS By Joshua A. Plumley Approved August 2009 __________________________________ __________________________________ Jeffrey D. Evanseck Ellen Gawalt Professor of Chemistry and Biochemistry Assistant Professor of Chemistry and Dissertation Director Biochemistry Committee Member Committee Member __________________________________ __________________________________ Douglas J. Fox
  • Defining Active Ingredient: the U.S

    Defining Active Ingredient: the U.S

    Defining Active Ingredient: The U.S. Food and Drug Administration’s Legal Interpretation of Regulatory Exclusivities December 10, 2019 Congressional Research Service https://crsreports.congress.gov R46110 SUMMARY R46110 Defining Active Ingredient: The U.S. Food and December 10, 2019 Drug Administration’s Legal Interpretation Erin H. Ward Legislative Attorney of Regulatory Exclusivities Whether many provisions of the Federal Food, Drug, and Cosmetic Act (FD&C Act) apply to a particular drug product turns in part on the novelty of the “active ingredient” of the drug in question. In particular, the Food and Drug Administration (FDA) must assess the novelty of the active ingredient in a new drug, comparing it to a previously approved drug’s active ingredient to determine whether the new drug qualifies for the five-year “new chemical entity” (NCE) exclusivity. FDA generally cannot accept new drug applications that refer to a drug with NCE exclusivity (i.e., rely on its clinical data and FDA’s approval of the drug) for five years. Companies that receive approval for drugs with new active ingredients generally enjoy a competitive advantage in the market while the exclusivity is in effect—and after, depending how long it takes for generic versions to receive approval once applications can be submitted. Comparing active ingredients can be technically quite complicated. For instance, compounds in a final drug product may convert to other compounds through chemical reactions inside the body before arriving at the site of the therapeutic effect. In addition, related but distinct drug molecules may be clinically indistinguishable or convert into the same pharmacologically or physiologically active component inside the body.
  • Isobutene Formation from 3-Hydroxy-3-Methylbutyrate (3-HMB

    Isobutene Formation from 3-Hydroxy-3-Methylbutyrate (3-HMB

    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2011 Isobutene formation from 3-hydroxy-3-methylbutyrate (3-HMB) by the Saccharomyces cerevisiae diphosphomevalonate decarboxylase (ScMDD) and directed enzyme evolution to improve enzyme function David Gogerty Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Biochemistry, Biophysics, and Structural Biology Commons Recommended Citation Gogerty, David, "Isobutene formation from 3-hydroxy-3-methylbutyrate (3-HMB) by the Saccharomyces cerevisiae diphosphomevalonate decarboxylase (ScMDD) and directed enzyme evolution to improve enzyme function" (2011). Graduate Theses and Dissertations. 10353. https://lib.dr.iastate.edu/etd/10353 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Isobutene formation from 3-hydroxy-3-methylbutyrate (3-HMB) by the Saccharomyces cerevisiae diphosphomevalonate decarboxylase (Sc MDD) and directed enzyme evolution to improve enzyme function by David Gogerty A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Biochemistry Program of Study Committee: Thomas A. Bobik, Major Professor Alan DiSpirito Basil Nikolau Donald Beitz Robert Brown Iowa State University Ames, Iowa 2011 Copyright © David Gogerty, 2011. All rights reserved. ii TABLE OF CONTENTS LIST OF FIGURES v LIST OF TABLES viii ACKNOWLEDGEMENTS ix ABSTRACT xi CHAPTER 1. General Introduction 1 I.
  • Relevance of N-Nitroso Compounds to Human Cancer: Exposures and Mechanisms

    WORLD HEALTH ORGANIZATION ' Ю INTERNATIONAL AGENCY FOR RESEARCH ON CANCER RELEVANCE OF N-NITROSO COMPOUNDS TO HUMAN CANCER: EXPOSURES AND MECHANISMS Proceedings of the IXth International Symposium on N-Nitroso Compounds, held in Baden, Austria, 1-5 SeptemЬеr 1986 Co-sponsored by: National Cancer Institute (USA) Dr M. Okada Giapan) and associated Japanese industrial sponsors Thermedics Inc. (USA) Ciba-Geigy (Switzerland) Imperial Chemical Industries (UK) EDITORS H. BARTSCH, T.K. 0 NЕILL & R. SCHULTE-HERMANN JAR SCIENTIFIC PUBLICATIONS NO. 84 INTERNATIONAL AGENCY FOR RESEARCH ON CANCER LYON 1987 CONTENTS Foreword.................................................................. 1 Introduction................................................................ 3 Overview................................................................... 5 Keynote address P.N. Magee ............................................................. 11 1. MOLECULAR AND BIOCHEMICAL MECHANISMS Biochemical events in nitrosamine-induced hepatocarcinogenesis: relevance of animal data to human carcinogenesis R.Schulte-Hermann .....................................................17 Biochemical and molecular effects of N-nitroso compounds in human cultured cells: an overview C.C. Harris .............................................................20 Activation of the human c-Ha-ras-1 proto-oncogene by in-vitro reaction with N-nitroso- methyl(acetoxymethyl)amine S. Hirani-Hojatti, J.R. Milligan & M.C. Archer ..............................26 Specificity of OЬ-alkylguanine-DNA
  • Division of Organic Chemistry

    Division of Organic Chemistry

    ORGN DIVISION OF ORGANIC CHEMISTRY S. Silverman and E. McLaughlin, Program Chairs SUNDAY MORNING Section A Pennsylvania Convention Center 116 New Reactions & Methodology S. M. Silverman, Organizer 8:00 1. Copper catalyzed reductive carbonylation of alkyl iodides. S. Zhao, N.P. Mankad 8:20 2. Sulfenate-anion-catalyzed diastereoselective aziridination of imines. Z. Zheng, P.J. Walsh 8:40 3. Cyanoalkylcopper species in carbon-carbon bond forming reactions. D.L. Silverio 9:00 4. New reactivity enabled by cation-π interactions. P.J. Walsh 9:20 5. Dipolar alkynyl-prins (DAP) cyclization for the rapid construction of complex polycycles. S. Abdul-Rashed, G. Alachouzos, A. Frontier 9:40 6. Subphthalocyanines and perylene-diimide derivatives in organic photovoltaics. L. Chockalingam Kasi Viswanath 10:00 7. Silylated α-aminonitriles for late-stage functionalization. T. Mathew, T. Yamato, S.G. Prakash 10:20 8. Synthesis of differentially substituted diynes via tandem nucleophilic addition/fragmentation pathways. A. Tavakoli, G.B. Dudley 10:40 9. Analogues of Bestmann’s ylide, Ph3P=C=C=O: Syntheses, structures and Lewis acid catalyzed cyclizations with organic substrates. C. Krempner 11:00 10. Diastereoselective alkynylations of β-(Bromo)iminium ions via copper(I) catalysis. S.O. Santana, W. Guan, M.P. Watson 11:20 11. Modular three-component difunctionalization of aryl/cyclohexenyl triflates via arynes and cyclohexynes. S. Cho, Q. Wang 11:40 12. 1,2-aminocyanation of alkenes via distal migration. Y. Kwon, Q. Wang Section B Pennsylvania Convention Center 117 Heterocycles & Aromatics S. M. Silverman, Organizer 8:00 13. Formal [4+2] cycloaddition between alkynes and allene-ynes to generate functionalized toluenes.
  • Chemical Synthesis of Staphyloferrin B Affords

    Chemical Synthesis of Staphyloferrin B Affords

    Chemical Synthesis of Staphyloferrin B Affords Insight into the Molecular Structure, Iron Chelation, and Biological Activity of a Polycarboxylate Siderophore Deployed by the Human Pathogen The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Madsen, Julie L. H., Timothy C. Johnstone, and Elizabeth M. Nolan. “ Chemical Synthesis of Staphyloferrin B Affords Insight into the Molecular Structure, Iron Chelation, and Biological Activity of a Polycarboxylate Siderophore Deployed by the Human Pathogen Staphylococcus Aureus .” Journal of the American Chemical Society 137, no. 28 (July 22, 2015): 9117-9127. As Published http://dx.doi.org/10.1021/jacs.5b04557 Publisher American Chemical Society (ACS) Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/104954 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Chemical Synthesis of Staphyloferrin B Affords Insight into the Molecular Structure, Iron Chelation, and Biological Activity of a Polycarboxylate Siderophore Deployed by the Human Pathogen Staphylococcus aureus Julie L. H. Madsen,a Timothy C. Johnstonea and Elizabeth M. Nolana,* aDepartment of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA *Corresponding author: [email protected] Phone: 617-452-2495 Fax: 617-324-0505 1 Abstract Staphyloferrin B (SB) is a citrate-based polycarboxylate siderophore produced and utilized by the human pathogen Staphylococcus aureus for acquiring iron when colonizing the vertebrate host. The first chemical synthesis of SB is reported, which enables further molecular and biological characterization and provides access to structural analogues of the siderophore.
  • NDA Classification Codes

    NDA Classification Codes

    MANUAL OF POLICIES AND PROCEDURES CENTER FOR DRUG EVALUATION AND RESEARCH MAPP 5018.2 POLICY AND PROCEDURES Office of Pharmaceutical Quality NDA Classification Codes Table of Contents PURPOSE ..............................................................................1 BACKGROUND ...................................................................1 POLICY .................................................................................1 NDA Classification Codes ...................................................2 RESPONSIBILITIES ...........................................................7 REFERENCES ......................................................................9 DEFINITIONS ......................................................................9 EFFECTIVE DATE ............................................................10 CHANGE CONTROL TABLE ..........................................10 PURPOSE This MAPP describes the new drug application (NDA) classification code assigned by the Center for Drug Evaluation and Research (CDER) to an NDA based on characteristics of the product in the application. This code was previously referred to as “Chemistry Classification Code.” BACKGROUND • The NDA classification code provides a way of categorizing new drug applications. The code evolved from both a management and a regulatory need to identify and group product applications based on certain characteristics, including their relationships to products already approved or marketed in the United States. Classifying applications based on these
  • Fda-2009-N-0184-00341

    Fda-2009-N-0184-00341

    DE PART:\-lENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD 20857 , 0 '1 NDA 021977 \ \ 1-'? ~ ,0 Chad A. Landmon Axinn Veltrop & Harkrider LLP 90 State House Square Hartford, CT 06103-3702 Docket No. FDA-2009-N-0184 Dear Mr. Landmon: Actavis Elizabeth LLC ("Actavis") has requested that the Food and Drug Administration ("FDA" or "Agency") reconsider its grant of new chemical entity exclusivity to Vyvanse (Iisdexamfetamine dimesylate) Capsules under sections 505(c)(3)(E)(ii) and 505U)(5)(F)(ii) of the Federal Food, Drug, and Cosmetic Act ("FDCA" or "the Act") and the implementing regu1ation at 21 CFR § 314.108. Actavis asserts that FDA should have granted Vyvanse a shorter period ofexclusivity under sections 505(c)(3)(E)(iii) and 505U)(5)(F)(iii) of the Act, and permitted the company to submit its abbreviated new drug application ("ANDA") for lisdexamfetamine dimesylate ("lisdexamfetamine") on January 28, 2009. We have carefully reviewed the submissions made to the Agency on this issue and additional relevant materials. For the reasons set forth below, we deny Actavis' request and affirm that lisdexamfetamine is entitled to NCE exclusivity. I. Summary Vyvanse Capsules contain lisdexamfetamine dimesylate as the active ingredient. Lisdexamfetamine consists of dextroamphetamine bonded covalently to lysine through an amide bond. Lisdexamfetamine is a prodrug that is metabolically converted to produce dextroamphetamine, which is responsible for the drug's activity. Under FDA's regulation at 21 CFR § 314.108, a non-ester covalently bonded molecule is considered the active moiety ofa drug and, if not previously approved, it will be considered a new chemical entity entitled to 5 years of exclusivity.
  • The Prodrug Approach: a Successful Tool for Improving Drug Solubility

    The Prodrug Approach: a Successful Tool for Improving Drug Solubility

    Review The Prodrug Approach: A Successful Tool for Improving Drug Solubility Daniela Hartmann Jornada, Guilherme Felipe dos Santos Fernandes, Diego Eidy Chiba, Thais Regina Ferreira de Melo, Jean Leandro dos Santos and Man Chin Chung * Received: 14 October 2015 ; Accepted: 15 December 2015 ; Published: 29 December 2015 Academic Editors: Thomas Rades, Holger Grohganz and Korbinian Löbmann Faculdade de Ciências Farmacêuticas, UNESP—University Estadual Paulista, Rodovia Araraquara Jaú Km 01, 14801-902 Araraquara, São Paulo, Brasil; [email protected] (D.H.J.); [email protected] (G.F.S.F.); [email protected] (D.E.C.); [email protected] (T.R.F.M.); [email protected] (J.L.S.) * Correspondence: [email protected]; Tel.: +55-16-3301-6962; Fax: +55-16-3301-6960 Abstract: Prodrug design is a widely known molecular modification strategy that aims to optimize the physicochemical and pharmacological properties of drugs to improve their solubility and pharmacokinetic features and decrease their toxicity. A lack of solubility is one of the main obstacles to drug development. This review aims to describe recent advances in the improvement of solubility via the prodrug approach. The main chemical carriers and examples of successful strategies will be discussed, highlighting the advances of this field in the last ten years. Keywords: prodrug; solubility; water-soluble prodrugs; solubility of prodrugs; molecular modification 1. Introduction Poor solubility is one of the main problems faced by researchers during drug development. Commonly, even with the use of current computational “filters” to minimize this problem, compounds that are active in vitro may lack adequate pharmacokinetic properties and/or may be difficult to formulate [1].
  • Novel Fidaxomicin Antibiotics Through Site-Selective Catalysis

    Novel Fidaxomicin Antibiotics Through Site-Selective Catalysis

    ARTICLE https://doi.org/10.1038/s42004-021-00501-6 OPEN Novel fidaxomicin antibiotics through site-selective catalysis ✉ David Dailler1,4, Andrea Dorst1,4, Daniel Schäfle2, Peter Sander2,3 & Karl Gademann 1 Fidaxomicin (FDX) is a marketed antibiotic for the treatment of Clostridioides difficile infec- tions (CDI). Fidaxomicin displays antibacterial properties against many Gram-positive bac- teria, yet the application of this antibiotic is currently limited to treatment of CDI. Semisynthetic modifications present a promising strategy to improve its pharmacokinetic properties and also circumvent resistance development by broadening the structural diversity of the derivatives. Here, based on a rational design using cryo-EM structural analysis, we 1234567890():,; implement two strategic site-selective catalytic reactions with a special emphasis to study the role of the carbohydrate units. Site-selective introduction of various ester moieties on the noviose as well as a Tsuji–Trost type rhamnose cleavage allow the synthesis of novel fidaxomicin analogs with promising antibacterial activities against C. difficile and Mycobacterium tuberculosis. 1 Department of Chemistry, University of Zurich, Zurich, Switzerland. 2 Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland. 3 National Center for Mycobacteria, University of Zurich, Zurich, Switzerland. 4These authors contributed equally: David Dailler, Andrea Dorst. ✉ email: [email protected] COMMUNICATIONS CHEMISTRY | (2021) 4:59 | https://doi.org/10.1038/s42004-021-00501-6 | www.nature.com/commschem 1 ARTICLE COMMUNICATIONS CHEMISTRY | https://doi.org/10.1038/s42004-021-00501-6 idaxomicin (1, tiacumicin B, lipiarmycin A3) constitutes an Over the past few decades, derivatization of natural products 18-membered narrow-spectrum macrolide antibiotic that was has been demonstrated to be an effective approach for the F 1–7 21 extracted from several actinomycetes and shows anti- development of new drug candidates .